CME

Mechanisms in Chronic Myelogenous Leukemia –
Accreditation Information

Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Imedex, LLC designates the following activities for AMA PRA Category 1 Credits™,
to a maximum of:

Biology and Pathophysiology of Chronic Myelogenous Leukemia
2.00 Credits
Clinical Manifestations and Laboratory Studies
1.50 Credits
Current Treatment of Chronic Myelogenous Leukemia – Imatinib and Allogeneic SCT
1.00 Credits
Mechanisms of Resistance
2.50 Credits
Treatment of Imatinib Resistant Chronic Myelogenous Leukemia
1.50 Credits
Monitoring of Treatment of Chronic Myelogenous Leukemia
2.00 Credits
Chronic Myelogenous Leukemia Treatment Guidelines
1.00 Credits
Questions on Management and Treatment: Side Effects and Drug Interactions
1.50 Credits

Participants who are eligible to claim AMA PRA Category 1 Credits™ must complete the self-assessment questions and module evaluation after reviewing the content of each Learning Module.


View the complete offering
of Learning Modules

Registration Required
To access CME activities and to view your personalized CME Profile page, which tracks completed learning modules, post-test scores and CME credits earned, and allows you to download printable CME certificates.

Send us your comments
We welcome your feedback and / or questions related to the educational content provided through Mechanisms in Chronic Myelogenous Leukemia.
Hours Calculated:

A CME Review of each Learning Module was conducted to determine the credit designation for each activity. The estimated time to complete each and the credits assigned are as follows:
 Estimated Completion TimeCredit AwardedRelease DateExpiration Date
Biology and Pathophysiology of Chronic Myelogenous Leukemia 120 minutes 2.00 11/30/08 11/30/09
Clinical Manifestations and Laboratory Studies 90 minutes 1.50 11/30/08 11/30/09
Current Treatment of Chronic Myelogenous Leukemia – Imatinib and Allogeneic SCT 60 minutes 1.00 11/30/08 11/30/09
Mechanisms of Resistance 150 minutes 2.50 11/30/08 11/30/09
Treatment of Imatinib Resistant Chronic Myelogenous Leukemia 90 minutes 1.50 11/30/08 11/30/09
Monitoring of Treatment of Chronic Myelogenous Leukemia 120 minutes 2.00 11/30/08 11/30/09
Chronic Myelogenous Leukemia Treatment Guidelines 60 minutes 1.00 11/30/08 11/30/09
Questions on Management and Treatment: Side Effects and Drug Interactions 90 minutes 1.50 11/30/08 11/30/09
   13.00   

Please contact Imedex with questions related to certification.

Developed and published in 2008 by Mechanisms in Medicine Inc. Copyright © Mechanisms in Medicine Inc. All rights reserved.
About Us | Contact Us | Terms of Use | Privacy Policy | Technical Requirements | Site Map | Help